Cholesterol Reconsidered: What It Is - What It Does and Why "Lower Is Always Better" Misses the Point

If you've ever had a doctor tell you your cholesterol is "too high" and handed you a prescription on the way out, you're not alone. Cholesterol has been cast as the villain of cardiovascular health for decades. But the full story is far more nuanced and far more interesting than a single number on a lab report.

What Is Cholesterol, Really?

Cholesterol is a waxy, fat-like molecule called a sterol. It's so essential to human life that your body makes most of it on its own. The liver and other tissues produce cholesterol through a multi-step process called the mevalonate pathway, with an enzyme called HMG-CoA reductase acting as the key regulator. Dietary cholesterol, from eggs, meat, and dairy, contributes a relatively modest amount, and the body compensates by adjusting its own production up or down depending on intake. This is why the relationship between dietary cholesterol and blood cholesterol levels is weaker and more variable than decades of public health messaging suggested.¹²³

What Does Cholesterol Actually Do?

This is where the story gets interesting. Cholesterol isn't just a circulating lipid waiting to clog your arteries. It's a structurally and metabolically indispensable molecule involved in virtually every system in your body.

1. Building and Maintaining Cell Membranes

Every cell in your body is surrounded by a membrane made partly of cholesterol. Cholesterol determines how fluid or rigid that membrane is, and it helps form specialized microdomains called lipid rafts, tiny platforms where receptors cluster, signals are transmitted, and ion channels open and close. Cholesterol is needed for cellular communication.

2. Brain Structure and Function

The brain contains roughly one-quarter of the body's total cholesterol, most of which is produced locally because cholesterol cannot cross the blood-brain barrier from the bloodstream. In the brain, cholesterol is essential for:

• Forming and maintaining myelin sheaths that insulate nerve fibers

• Enabling synaptic vesicle fusion and neurotransmitter release

• Producing neurosteroids like allopregnanolone, which modulate GABA receptors and influence mood, stress resilience, and sleep

This neurobiological role helps explain why very low cholesterol levels have been associated with increased risk of depression and suicidal behavior in some observational studies, a topic worth discussing with your clinician if you have mood concerns alongside low lipid levels.

3. Hormone Production

Cholesterol is the raw material for every steroid hormone your body makes. Inside the mitochondria of adrenal and gonadal cells, an enzyme called CYP11A1 converts cholesterol into pregnenolone, the "mother hormone" that initiates the cascade producing:

• Cortisol (stress response)

• Aldosterone (blood pressure and fluid balance)

• Testosterone, estrogen, and progesterone (sex hormones)

• DHEA (energy, immunity, and aging)

When cholesterol availability is disrupted, whether by disease, malnutrition, or aggressive pharmacologic lowering, downstream hormone production can be affected. 

4. Vitamin D Synthesis

Cholesterol in the skin is converted to vitamin D3 (cholecalciferol) when exposed to UVB sunlight. Vitamin D3 then travels to the liver and kidneys for activation. This links cholesterol directly to calcium metabolism, immune function, mood regulation, and gene expression, all areas where vitamin D plays a documented role.

5. Bile Acid Production and Digestive Health

The liver converts cholesterol into bile acids, which are released into the small intestine to emulsify dietary fats and enable absorption of fat-soluble vitamins A, D, E, and K. This is actually the primary route by which the body eliminates excess cholesterol. Disruptions in bile acid metabolism can impair fat digestion, reduce micronutrient absorption, and affect the gut microbiome, with downstream effects on inflammation, immune function, and metabolic health.

How Cholesterol Gets Around: Lipoproteins

Because cholesterol is fat-soluble and blood is water-based, cholesterol must be packaged into transport vehicles called lipoproteins. You've likely heard of the main players:

• LDL (low-density lipoprotein): Carries cholesterol from the liver to peripheral tissues. Often called "bad" cholesterol, though the picture is more nuanced. Particle size, number (measured as ApoB), and oxidation status matter more than total LDL-C alone.

• HDL (high-density lipoprotein): Facilitates reverse cholesterol transport, carrying cholesterol back to the liver for recycling or excretion. Often called "good" cholesterol.

• VLDL and IDL: Triglyceride-rich particles produced by the liver; precursors to LDL.

• Lipoprotein(a) [Lp(a)]: A genetically determined lipoprotein with prothrombotic and pro-inflammatory properties; an independent cardiovascular risk factor not well captured by standard lipid panels.

What Drives Elevated Cholesterol?

Elevated LDL-C is not simply the result of eating too many eggs. From a functional perspective, elevated cholesterol production or impaired clearance can reflect:

• Insulin resistance: Drives increased hepatic VLDL production and alters LDL particle characteristics

• Hypothyroidism: Reduces LDL receptor activity, raising circulating LDL-C

• Chronic inflammation: Alters lipoprotein metabolism and oxidative modification of LDL particles

• Genetic factors: Familial hypercholesterolemia involves LDL receptor mutations that dramatically impair clearance

• Dietary pattern: Ultra-processed foods, refined carbohydrates, and trans fats affect lipid profiles differently than whole-food saturated fats

This is why treating a cholesterol number without understanding the underlying physiology can miss the root cause entirely.

What About Statins? The Mevalonate Pathway Goes Deeper

Statins work by blocking HMG-CoA reductase, the enzyme that regulates cholesterol synthesis. This effectively lowers LDL-C by reducing hepatic cholesterol production and upregulating LDL receptors. For people with established cardiovascular disease, statins may provide meaningful risk reduction.

However, the mevalonate pathway produces more than just cholesterol. Blocking it also reduces the synthesis of:

• Coenzyme Q10 (CoQ10): A critical component of the mitochondrial electron transport chain that turns food into energy (ATP). Reduced CoQ10 has been linked to statin-associated muscle pain and fatigue, likely through impaired ATP production and increased oxidative stress.

• Dolichols: Required for proper protein shape and function and cellular quality control. Lower levels have been found in Alzheimer’s disease.

• Farnesyl and geranylgeranyl pyrophosphate: Molecules that anchor signaling proteins to cell membranes to facilitate cellular communication.

These downstream effects don't mean statins are universally harmful, but they do mean that statin therapy warrants individualized risk-benefit assessment, monitoring for side effects, and consideration of CoQ10 supplementation, especially in symptomatic patients.

A More Complete Picture of Cardiovascular Risk

Cholesterol is one piece of a much larger puzzle. Emerging evidence and clinical experience suggest that cardiovascular risk is better captured by:

• ApoB: Reflects the total number of atherogenic lipoprotein particles; a stronger predictor than LDL-C alone

• Lp(a): Genetically determined; associated with increased clotting and plaque risk

• Triglyceride/HDL ratio: A proxy for insulin resistance

• hs-CRP: Reflects systemic inflammation

• Fasting insulin and HbA1c: Markers of metabolic health and insulin resistance

• Coronary artery calcium (CAC) score: Directly measures plaque burden

The Bottom Line

Cholesterol is not a villain. It is a central node in human metabolism, essential for brain function, hormone production, vitamin D synthesis, and cellular integrity. Its levels in the blood are shaped by genetics, metabolic health, thyroid function, inflammation, diet quality, and more.

A truly comprehensive approach to cardiovascular and metabolic health doesn't just ask "how do we lower this number?" It asks: "What is driving this pattern, and what does this person's whole metabolic picture look like?"

That's the kind of personalized, root-cause thinking that functional nutrition brings to cholesterol care.

Sources:

1. Dietary Cholesterol and Cardiovascular Risk: A Science Advisory from the American Heart Association. Circulation. 2019. PMCID: PMC6682969.

2. Dietary Cholesterol and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Am J Clin Nutr. 2015. PMCID: PMC11441719.

3. Keys A et al. Serum cholesterol response to changes in dietary lipids. Am J Clin Nutr. 1966. PMCID: PMC1079611.

4. Bhatt DL et al. Cardiovascular risk reduction with icosapentaenoic acid. N Engl J Med. 2019.

5. Schwalfenberg GK, Genuis SJ. The Importance of Magnesium in Clinical Healthcare. Scientifica. 2017. PMCID: PMC5637834.

6. Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol. 2009.

7. Bhattacharya S et al. Statin-associated myopathy and CoQ10 depletion. J Clin Lipidol. 2014.

8. Laufs U et al. Pleiotropic effects of statins. Circulation. 2005.

9. Ridker PM et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008.

10. Nordestgaard BG et al. Lipoprotein(a) as a cardiovascular risk factor. Eur Heart J. 2010.